References
- Bartalena L, Pinchera A, Marcocci C. Management of Graves’ ophthalmopathy: reality and perspectives. Endocr Rev 2000;21:168–199
- Damato BE, Allan D, Murray SB, Lee WR. Senile atrophy of the human lacrimal gland: the contribution of chronic inflammatory disease. Br J Ophthalmol 1984;68:674–680
- James DG, Anderson R, Langley D, Ainslie D. Ocular sarcoidosis. Br J Ophthalmol 1964;48:461–470
- Itescu S, Brancato LJ, Buxbaum J, et al. Diffuse infiltrative CD8 lymphocytosis syndrome in human immunodeficiency virus (HIV) infection: A host immune response associated with HLA-DR5. Ann Intern Med 1990;112:3–10
- Foulks G, Bron AJ. A clinical description of meibomian gland dysfunction. Ocul Surf 2003;1:107–126
- Bron AJ, Tiffany JM. The contribution of meibomian disease to dry eye. Ocul Surf 2004;2:149–165
- Fonn D, Situ P, Simpson T. Hydrogel lens dehydration and subjective comfort and dryness ratings in symptomatic and asymptomatic contact lens wearers. Optom Vis Sci 1999;76:700–704
- Gilbard JP, Farris RL. Ocular surface drying and tear film osmolarity in thyroid eye disese. Acta Ophthalmol 1983;61:108–116
- Wiersinga WM, Perros P, Kahaly GJ, et al. Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers. Eur J Endocrinol 2006;155:387–389
- Khalil HA, De Keizer RJ, Bodelier VM, Kijlstra A. Secretory IgA andlysozyme in tears of patients with Graves’ ophthalmopathy. Doc Ophthalmol 1989;72:29–34
- Eckstein AK, Finkenrath A, Heiligenhaus A, et al. Dry eye syndrome in thyroid-associated ophthalmopathy: lacrimal expression of TSH receptor suggests involvement of TSHR-specific autoantibodies. Acta Ophthalmol Scand 2004;82:291–297
- Bartalena L, Baldeschi L, Dickinson A, et al. Consensus statement of the European Group on Graves’ orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol. 2008;158:273–285
- EUGOGO Atlas. Protocol for assessment for Graves’ orbitopathy and completion of Case Record Form. Available at: www.eugogo.eu/_downloads/clinical_evaluation_GO.pdf
- The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop. Ocul Surf 2007;5:75–92 (PMID: 17508116)
- Bron AJ, Evans VE, Smith JA. Grading of cornea and conjunctival staining in the context of other dry eye tests. Cornea 2003;22:640–650
- Schiffman R, Christianson D, Jacobsen G, et al. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol 2000;118:615–621
- Gupta A, Sadeghi PB, Akpek EK. Occult thyroid eye disease in patients presenting with dry eye symptoms. Am J Ophthalmol 2009;147:919–923
- Chang TC, Huang KM, Chang TJ, Lin SL. Correlation of orbital computed tomography and antibodies in patients with hyperthyroid Graves’ disease. Clin Endocrinol 1990;32:551–558
- Mohaseb K, Linder M, Rootman J, et al. Development and validation of a patient symptom questionnaire to facilitate early diagnosis of thyroid-associated orbitopathy in Graves' disease. Orbit 2008;27:419–425
- Achtidis V, Tentolouris N, Theodoropoulou S, et al. Dry eye in Graves ophthalmopathy: Correlation with corneal hypoesthesia. Eur J Ophthalmol 2013;23:473–479
- Villani E, Viola F, Sala R, et al. Corneal involvement in Graves’ orbitopathy: an in vivo confocal study. Invest Ophthalmol Vis Sci 2010;51:4574–4578
- Huang D, Xu N, Song Y, et al. Inflammatory cytokine profiles in the tears of thyroid-associated ophthalmopathy. Graefes Arch Clin Exp Ophthalmol 2012;250:619–625
- Iskeleli G, Karakoc Y, Abdula A. Tear film osmolarity in patients with thyroid ophthalmopathy. Jpn J Ophthalmol 2008;52:323–326
- Luo L, Li DQ, Doshi A, et al. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest Ophthalmol Vis Sci 2004;45:4293–4301